Arrowhead Pharmaceuticals Inc ARWR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:20 PM EDT
25.00UNCH (UNCH)
Volume
91,559
Close
25.00quote price arrow down-0.16 (-0.64%)
Volume
640,455
52 week range
20.67 - 41.36
Loading...
  • Open25.15
  • Day High25.38
  • Day Low24.86
  • Prev Close25.16
  • 52 Week High41.36
  • 52 Week High Date05/08/23
  • 52 Week Low20.67
  • 52 Week Low Date12/01/23

Key Stats

  • Market Cap3.097B
  • Shares Out123.90M
  • 10 Day Average Volume0.84M
  • Dividend-
  • Dividend Yield-
  • Beta0.95
  • YTD % Change-18.3

KEY STATS

  • Open25.15
  • Day High25.38
  • Day Low24.86
  • Prev Close25.16
  • 52 Week High41.36
  • 52 Week High Date05/08/23
  • 52 Week Low20.67
  • 52 Week Low Date12/01/23
  • Market Cap3.097B
  • Shares Out123.90M
  • 10 Day Average Volume0.84M
  • Dividend-
  • Dividend Yield-
  • Beta0.95
  • YTD % Change-18.3

RATIOS/PROFITABILITY

  • EPS (TTM)-2.77
  • P/E (TTM)-9.02
  • Fwd P/E (NTM)-11.77
  • EBITDA (TTM)-285.321M
  • ROE (TTM)-110.45%
  • Revenue (TTM)181.74M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-166.63%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arrowhead Pharmaceuticals Inc

 

Profile

MORE
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The Company's Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting...
Douglass Given M.D., Ph.D.
Independent Chairman of the Board
Christopher Anzalone Ph.D.
President, Chief Executive Officer, Director
Patrick O'Brien J.D.
Chief Operating Officer, General Counsel, Company Secretary
Kenneth Myszkowski
Chief Financial Officer
Address
177 E Colorado Blvd, Suite 700
Pasadena, CA
91105
United States

Top Peers

SYMBOLLASTCHG%CHG
IMCR
Immunocore Holdings PLC
61.04-0.87-1.41%
ACLX
Arcellx Inc
52.42-0.25-0.47%
MOR
MorphoSys AG
17.94-0.04-0.22%
VCEL
Vericel Corp
49.52+2.58+5.50%
RYTM
Rhythm Pharmaceuticals Inc
39.35-4.53-10.32%